{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:45:12Z","timestamp":1791229512969,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.preghy.2018.03.007","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T20:00:53Z","timestamp":1521403253000},"page":"234-239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["A clinical evaluation of placental growth factor in routine practice in high-risk women presenting with suspected pre-eclampsia and\/or fetal growth restriction"],"prefix":"10.1016","volume":"14","author":[{"given":"L.","family":"Ormesher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.D.","family":"Johnstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Shawkat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Dempsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Chmiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Ingram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.E.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.E.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preghy.2018.03.007_b0005","series-title":"Saving Lives, Improving Mothers\u2019 Care: Lessons learned to inform future maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009-12","author":"Knight","year":"2014"},{"key":"10.1016\/j.preghy.2018.03.007_b0010","doi-asserted-by":"crossref","first-page":"f108","DOI":"10.1136\/bmj.f108","article-title":"Maternal and fetal risk factors for stillbirth: population based study","volume":"346","author":"Gardosi","year":"2013","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.preghy.2018.03.007_b0015","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1161\/HYPERTENSIONAHA.107.107565","article-title":"Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study","volume":"51","author":"Chappell","year":"2008","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.preghy.2018.03.007_b0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.preghy.2014.02.001","article-title":"The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP","volume":"4","author":"Tranquilli","year":"2014","journal-title":"Pregnancy Hypertens."},{"issue":"19","key":"10.1016\/j.preghy.2018.03.007_b0025","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1161\/CIRCULATIONAHA.113.003215","article-title":"Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study","volume":"128","author":"Chappell","year":"2013","journal-title":"Circulation"},{"issue":"7491","key":"10.1016\/j.preghy.2018.03.007_b0030","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/bmj.38380.674340.E0","article-title":"Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies","volume":"330","author":"Duckitt","year":"2005","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.preghy.2018.03.007_b0035","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.preghy.2018.03.007_b0040","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.placenta.2004.09.001","article-title":"Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women","volume":"26","author":"Rajakumar","year":"2005","journal-title":"Placenta"},{"issue":"3","key":"10.1016\/j.preghy.2018.03.007_b0045","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/1933719109351320","article-title":"A gel-free quantitative proteomics analysis of factors released from hypoxic-conditioned placentae","volume":"17","author":"Blankley","year":"2010","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.preghy.2018.03.007_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.placenta.2016.03.010","article-title":"Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction","volume":"42","author":"Benton","year":"2016","journal-title":"Placenta"},{"issue":"1","key":"10.1016\/j.preghy.2018.03.007_b0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.preghy.2018.03.007_b0060","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.preghy.2012.04.101","article-title":"OS100. Plasma placental growth factor (PLGF) measurement in women presenting with suspected pre-eclampsia: the pelican study","volume":"2","author":"Chappell","year":"2012","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.preghy.2018.03.007_b0065","article-title":"Prediction of delivering a small for gestational age infant and adverse perinatal outcome in women with suspected pre-eclampsia","author":"Griffin","year":"2017","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2018.03.007_b0070","unstructured":"The National Institute for Health and Care Excellence (NICE) Diagnostics Assessment Panel. PlGF-based testing to help diagnose suspected pre-eclampsia (Triage PlGF test, Elecsys immunoassay sFlt-1\/PlGF ratio, DELFIA Xpress PlGF 1-2-3 test, and BRAHMS sFlt-1 Kryptor\/BRAHMS PlGF plus Kryptor PE ratio). Available at: https:\/\/www.nice.org.uk\/guidance\/dg23. 2016. [Accessed April 2017]."},{"key":"10.1016\/j.preghy.2018.03.007_b0075","unstructured":"The National Institute for Health and Care Excellence (NICE). Hypertension in pregnancy: diagnosis and management. NICE Guidelines (CG107). Available at: https:\/\/www.nice.org.uk\/guidance\/cg107. 2011. [Accessed April 2017]."},{"key":"10.1016\/j.preghy.2018.03.007_b0080","unstructured":"RCOG. The Investigation and Management of the Small\u2013for\u2013Gestational\u2013Age Fetus. Green-top Guideline No.31. 2014."},{"issue":"5","key":"10.1016\/j.preghy.2018.03.007_b0085","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/01.AOG.0000437382.03963.88","article-title":"Hypertension in Pregnancy","volume":"122","author":"Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy","year":"2013","journal-title":"Obstet Gynecol."},{"issue":"8788","key":"10.1016\/j.preghy.2018.03.007_b0090","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0140-6736(92)91342-6","article-title":"Customised antenatal growth charts","volume":"339","author":"Gardosi","year":"1992","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.preghy.2018.03.007_b0095","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.preghy.2013.01.004","article-title":"Determination of placental growth factor (PlGF) levels in healthy pregnant women without signs or symptoms of preeclampsia","volume":"3","author":"Saffer","year":"2013","journal-title":"Pregnancy Hypertens."},{"issue":"12","key":"10.1016\/j.preghy.2018.03.007_b0100","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1111\/j.1538-7836.2011.04526.x","article-title":"Heparin promotes soluble VEGF receptor expression in human placental villi to impair endothelial VEGF signaling","volume":"9","author":"Drewlo","year":"2011","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.preghy.2018.03.007_b0105","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/HYPERTENSIONAHA.111.182170","article-title":"Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia","volume":"59","author":"Rajakumar","year":"2012","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.preghy.2018.03.007_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.11.015","article-title":"Maternal plasma angiogenic index-1 (placental growth factor\/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study","volume":"214","author":"Korzeniewski","year":"2016","journal-title":"Am. J. Obstet. Gynecol."}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778918300230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778918300230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:19:31Z","timestamp":1779895171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778918300230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":22,"alternative-id":["S2210778918300230"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2018.03.007","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732892912.793579078","asserted-by":"object"}]},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A clinical evaluation of placental growth factor in routine practice in high-risk women presenting with suspected pre-eclampsia and\/or fetal growth restriction","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2018.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}